Industry News
Australia Expands Medical Cannabis Access: The Land Down Under Goes Green
Australia is rapidly expanding its medical cannabis program with new pathways for patient access, domestic cultivation licenses, and growing public support for reform.
Australia's Cannabis Evolution
Australia's medical cannabis market is experiencing rapid expansion. Since legalization in 2016, the program has grown from a few hundred patients to tens of thousands, with momentum accelerating.
Growth Numbers
Australia's medical cannabis program is booming:
- Over 30,000 patients accessing medical cannabis (up from 3,000 in 2018)
- 200+ approved products available through the Therapeutic Goods Administration
- Cultivation licenses granted to multiple domestic producers
- Annual growth exceeding 100% year-over-year
How Australian Access Works
The Therapeutic Goods Administration (TGA) oversees cannabis access through several pathways:
Special Access Scheme (SAS-B) — Doctors can prescribe to individual patients with government approval
Authorized Prescriber — Approved doctors can prescribe without per-patient government approval
Clinical Trials — Patients can access cannabis through approved research studies
Conditions Treated
Australian patients commonly access cannabis for:
- Chronic pain
- Cancer-related symptoms
- Epilepsy
- Multiple sclerosis
- PTSD and anxiety
- Palliative care
The Industry Landscape
Australia's cannabis industry is developing rapidly:
- Domestic cultivation is scaling to reduce import dependency
- Export ambitions — Australia aims to become a regional supplier
- Research investment — Universities establishing cannabis research programs
- Corporate interest — ASX-listed cannabis companies attracting investment
Challenges
- Access barriers — The prescribing process is still cumbersome for some patients
- Cost — Products are often expensive and not covered by insurance
- Stigma — Some healthcare providers remain hesitant to prescribe
- Regulatory complexity — Federal and state regulations can conflict
Budbo's Asia-Pacific Outlook
Australia represents a key market for Budbo's international expansion:
- Growing patient population needing discovery tools
- Dispensary and pharmacy partners needing technology
- A sophisticated consumer base comfortable with technology
Australia is proof that cannabis reform is a global phenomenon. Budbo is building for this global market.
- australia
- medical cannabis
- international cannabis
- TGA
- cannabis regulation
From the Budbo archive. Details about products, prices and laws reflect the time of writing.